Z-1496-2018 Class II Terminated

Recalled by Diagnostic Hybrids, Inc. — Athens, OH

Recall Details

Product Type
Devices
Report Date
May 2, 2018
Initiation Date
April 4, 2017
Termination Date
August 28, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
101 kits

Product Description

MicroVue CIC-C1q EIA, Model A001. An enzyme immunoassay for the detection of circulating immune complexes in human serum or plasma. The assay uses highly pure, functional human C1q coated in the solid phase to capture immune complexes (CIC). In the first stage, CIC in the diluted patient samples and HAGG in the controls and standards are dispensed into the C1q coated assay wells. After incubation, unbound material is removed in a washing step and a ready to use conjugate (goat anti-human Ig-HRP) is added. After a second incubation, unbound conjugate is washed away. After addition of a substrate and a short incubation interval, the quantity of CIC in the sample (¿g Eq/ml) can be determined by comparison to a standard curve.

Reason for Recall

There is a potential for the slope of the standard curve to fail to meet the assay validation requirements for the assay.

Distribution Pattern

The products were distributed to the following US states: NY, TX, CO, UT. The products were distributed to the following foreign countries: Switzerland.

Code Information

Lot 084007